Access to Vaccines: Cross-Country Comparison of Availability and Affordability of Essential Vaccines

Abstract

S49 vaccines in LMICs is not an issue, many vaccines in LMICs' NIP were mainly supported by international organizations such as GAVI. CONCLUSIONS: We found variation in access to vaccine in both the availability of the vaccine and types and numbers of vaccines provided in the country's NIP. Variation are higher when compare across countries with different income level.